Health TrialsbyHealthPanel

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

ConditionPTCL
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe First Affiliated Hospital with Nanjing Medical University

About this trial

The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

(1) Age: 18 years and older; (2) Gender: Male/Female; (3) Diagnosed with PTCL; (4) Received chidamide as maintenance therapy after first-line treatment.

Disqualifiers

(1) Patients with other types of lymphomas; (2) Pregnant women.

Trial population

Adults diagnosed with PTCL, who have undergone first-line treatment and are using chidemide as maintenance therapy.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • chidamide

    Drug

    This subset of patients received chidamide as first-line maintenance therapy.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

PFS

progression free survival

Time frame
2 years

Secondary outcomes

1

OS

overall survival

Time frame
2 years
2

CR

complete remission

Time frame
2 years
3

DOR

duration of remission

Time frame
2 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The First Affiliated Hospital with Nanjing Medical University

Lead sponsor

Source ClinicalTrials.gov
Apply now